Molecular Physiology Core Applied to Acute Lung Injury

分子生理学核心应用于急性肺损伤

基本信息

  • 批准号:
    7936177
  • 负责人:
  • 金额:
    $ 51.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-30 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This P30 application seeks to provide resources to recruit Dr. Eric Schmidt to lead the Molecular Physiology and Imaging Core (MPIC) in the Division of Pulmonary Sciences and Critical Care Medicine. The Division is based at the University of CO Denver and encompasses the University's affiliate faculty (at National Jewish Health, Denver Health and Hospital System, and the Denver VA Hospital). The research expertise encompasses acute lung injury (ALI), pulmonary hypertension, lung cancer, COPD, occupational medicine, interstitial lung diseases and asthma, among others. The Division is an integral participant of the NIH-funded CO Clinical and Translational Sciences, University of CO Comprehensive Cancer Center, and Program Project Grant in the Cardiovascular Pulmonary Research (CVP) Lab. The Division has membership in every NHLBI Lung Division Clinical Network, including the ARDSnet, COPDnet, IPFnet, and the Asthma Clinical Research Network (ACRN). The Division has gathered substantial institutional resources to implement the Program in Translational Lung Research, which will support the MPIC. The MPIC will be built with a focus on ALI, in its protean manifestations. This emphasis is based on the overall relevance of ALI and the breadth of pathogenetic mechanisms, which ultimately are part of several lung disease processes. The expertise of the MPIC will also extend to studies in pulmonary hypertension, interstitial lung disease, and cigarette smoke induced lung injury. The choice to recruit Dr. Schmidt to establish this Core was based on a selective process of recruitment, professional development, career support, and long-term retention plans. With the direct support of the PI, Dr. Mark Geraci, and Drs. Ivor Douglas and Rubin Tuder, Dr. Schmidt will coordinate the interaction across affiliated programs & the Division & Departments within the medical school (Medicine, Anesthesiology and Pediatrics), the Colorado CTSI, and programmatic initiatives involving the CVP, and the imaging core at the Department of Medicine. A research committee, which will include several established NIH-funded investigators in lung diseases, will assist Dr. Schmidt with the administration of the Core. A plan to assess the Core, scientific productivity, and Dr. Schmidt's career development & mentorship are in place. This proposal targets the integrated physiological and imaging study of acute lung injury, which compromises 190,000 patients per year. The proposed MPIC provides a central experimental element for the successful translation from/to clinical data and relevant model systems, as it synergizes with a range of other methodologies, which in isolation cannot address the complexity of pulmonary diseases, including acute lung injury.
描述(由申请人提供):此P30申请旨在为招募Eric Schmidt博士提供资源,以领导肺科学和重症医学部门的分子生理学和成像核心(MPIC)。该部门位于丹佛大学,包括该大学的附属教师(在国家犹太健康,丹佛健康和医院系统以及丹佛VA医院)。研究专长包括急性肺损伤、肺动脉高压、肺癌、慢性阻塞性肺病、职业医学、肺间质性疾病和哮喘等。该科是美国国立卫生研究院资助的CO临床和转化科学、CO大学综合癌症中心和心血管肺研究(CVP)实验室项目资助的不可或缺的参与者。该科是NHLBI肺科临床网络的成员,包括ARDSnet、COPDnet、IPFnet和哮喘临床研究网络(ACRN)。该科已经收集了大量的机构资源来实施转化肺研究项目,这将支持MPIC。MPIC的建设将以各种形式的ALI为重点。这一重点是基于ALI的整体相关性和病理机制的广度,这最终是几个肺部疾病过程的一部分。MPIC的专业知识还将扩展到肺动脉高压、间质性肺疾病和香烟烟雾引起的肺损伤的研究。选择Schmidt博士来建立这个核心是基于一个选择性的招聘过程、专业发展、职业支持和长期保留计划。在PI的直接支持下,Mark Geraci博士和dr。Ivor Douglas和Rubin Tuder, Schmidt博士将协调附属项目和医学院(医学、麻醉学和儿科)、科罗拉多CTSI以及涉及CVP的项目倡议和医学系成像核心的部门之间的互动。一个研究委员会将协助施密特博士管理Core,该委员会将包括几位由nih资助的肺病研究人员。一项评估核心、科学生产力以及施密特博士的职业发展和指导的计划已经到位。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Role of Apoptosis in Amplifying Inflammatory Responses in Lung Diseases.
  • DOI:
    10.4137/jcd.s5375
  • 发表时间:
    2010-07-20
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Schmidt EP;Tuder RM
  • 通讯作者:
    Tuder RM
Hyperoxia and apoptosis. Too much of a good thing?
高氧和细胞凋亡。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARK W GERACI其他文献

MARK W GERACI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARK W GERACI', 18)}}的其他基金

Common targeting of the prostacyclin-PPARy axis in COPD and lung cancer
COPD 和肺癌中前列环素-PPARy 轴的共同靶向
  • 批准号:
    8320228
  • 财政年份:
    2011
  • 资助金额:
    $ 51.4万
  • 项目类别:
Common targeting of the prostacyclin-PPARy axis in COPD and lung cancer
COPD 和肺癌中前列环素-PPARy 轴的共同靶向
  • 批准号:
    8490706
  • 财政年份:
    2011
  • 资助金额:
    $ 51.4万
  • 项目类别:
Common targeting of the prostacyclin-PPARy axis in COPD and lung cancer
COPD 和肺癌中前列环素-PPARy 轴的共同靶向
  • 批准号:
    8097154
  • 财政年份:
    2011
  • 资助金额:
    $ 51.4万
  • 项目类别:
53rd Annual Thomas L Petty Aspen Lung Conference: Systems Biology of Lung Disease
第 53 届 Thomas L Petty Aspen 肺病年度会议:肺部疾病的系统生物学
  • 批准号:
    8005685
  • 财政年份:
    2010
  • 资助金额:
    $ 51.4万
  • 项目类别:
Lung Genomics Research Consortium
肺基因组学研究联盟
  • 批准号:
    7939886
  • 财政年份:
    2009
  • 资助金额:
    $ 51.4万
  • 项目类别:
Prostacyclin Synthase and Receptors in Pulmonary Arterial Hypertension
肺动脉高压中的前列环素合酶和受体
  • 批准号:
    7824361
  • 财政年份:
    2009
  • 资助金额:
    $ 51.4万
  • 项目类别:
Lung Genomics Research Consortium
肺基因组学研究联盟
  • 批准号:
    8305295
  • 财政年份:
    2009
  • 资助金额:
    $ 51.4万
  • 项目类别:
Molecular Physiology Core Applied to Acute Lung Injury
分子生理学核心应用于急性肺损伤
  • 批准号:
    7859480
  • 财政年份:
    2009
  • 资助金额:
    $ 51.4万
  • 项目类别:
Mechanisms of Prostacyclin signaling in Pulmonary Arterial Hypertension
肺动脉高压中前列环素信号传导机制
  • 批准号:
    7662797
  • 财政年份:
    2009
  • 资助金额:
    $ 51.4万
  • 项目类别:
Lung Genomics Research Consortium
肺基因组学研究联盟
  • 批准号:
    7853298
  • 财政年份:
    2009
  • 资助金额:
    $ 51.4万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 51.4万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 51.4万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 51.4万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 51.4万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 51.4万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 51.4万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 51.4万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 51.4万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 51.4万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 51.4万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了